Quantcast Factors Influencing The Pharmacokinetics Of Prophylactic Posaconazole Oral Suspension - Congoo
 
 
CANCER Log In
Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension
Have an interest in this Story?
Sign Up for Real-Time email updates
MDLinx  | February 13, 2012

Vehreschild JJ et al. The authors developed a prediction basis for mean posaconazole concentrations in AML/MDS patients. Patient weight, presence of diarrhea, and concomitant medication (chemotherapy and pantoprazole) showed significant effects on posaconazole exposure. Corresponding adjustments of ...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Rob Guenthner Rob Guenthner
Partner
Healthcare Industry
Robert Miller Robert Miller
Member/Manager
Healthcare Industry

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2012 Congoo.com. All Rights Reserved.